Statutory Holiday
News
What’s happening at isoSolutions
Upcoming conferences and trade shows, plus the latest from our team and across the nuclear medicine industry.
Our office is closed for the weekend. We reopen on Monday.
November 2026
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 12 | 13 | 14 | |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 |
- Conference
- Exhibition
- Trade Show
- Statutory Holiday
Statutory Holiday
Christmas Day
Statutory Holiday
Thanksgiving Day
Exhibition
Global Nuclear Medicine Expo
An exhibition showcasing the latest in medical isotopes, imaging equipment, and radiochemical innovation from suppliers across North America.
Statutory Holiday
National Day for Truth and Reconciliation
Conference
CSNM 2026
The Chinese Society of Nuclear Medicine's annual conference, bringing together clinicians, researchers, and industry partners across greater China. isoSolutions will exhibit its radiopharmaceutical and QC instrumentation line.
Statutory Holiday
Labour Day
Trade Show
Pacific Northwest Radiopharmacy Roundtable
A regional gathering for radiopharmacy directors and procurement leads to discuss supply chain resilience and emerging isotope technologies.
Statutory Holiday
BC Day
Statutory Holiday
Canada Day
Statutory Holiday
Victoria Day
Statutory Holiday
Good Friday
Statutory Holiday
Family Day
Past event
WFNMB 2026 Congress
isoSolutions exhibited a complete portfolio of materials, equipment and solutions for the preparation of theranostics, with a primary focus on Lutetium-177 and Gallium-68 workflows. Marvin Calderon and Julian Walcott met visitors at Booth #56.
Statutory Holiday
New Year’s Day
Past event
CANM 2024 Annual Scientific Meeting
The Canadian Association of Nuclear Medicine annual scientific meeting, where the isoSolutions team met members from across Canada.
Past event
EANM 2023 — 36th Annual Congress
The 36th Annual Congress of the European Association of Nuclear Medicine. Our team attended to discuss collaboration on precision medicine and theranostics.
Past event
SNMMI 2023 Annual Meeting
The world's largest event focused exclusively on the educational and networking needs of the nuclear medicine and molecular imaging community. isoSolutions exhibited at Booth #1065.
Past event
SNMMI 2022 Annual Meeting
The SNMMI Annual Meeting came to isoSolutions' home city, bringing together the nuclear medicine and molecular imaging community.
Past event
EANM’21 Annual Congress
The European Association of Nuclear Medicine held its 2021 annual congress as a virtual event.
WFNMB 2026 Congress — Cartagena, Colombia
Join our team for a full showcase of integrated theranostics workflows and generator technology.
Read More WFNMB 2026 Congress — Cartagena, Colombia
Health Canada Drug Master File (DMF) Submission
68Ge/68Ga generator DMF filed in collaboration with iThemba LABS.
Read More Health Canada Drug Master File (DMF) Submission
Happy Chinese Lunar New Year 2025
isoSolutions wishes its employees, associates, partners, customers, and suppliers in China and worldwide celebrating the Lunar New Year good spirits, good health, happiness, and…
Read More Happy Chinese Lunar New Year 2025
Molybdenum ( Mo-100)
isoSolutions is pleased to announce the availability of Molybdenum Mo-100 (Radiochemical) with high enrichment and high purity from a cGMP facility. Mo-100 is a…
Read More Molybdenum ( Mo-100)
7th Theranostic World Congress.
isoSolutions is participating in the 7th Theranostics World Congress in Santiago, Chile. We will be represented by Marvin Calderon at this conference. Please email…
Read More 7th Theranostic World Congress.
Happy New Lunar Year 2024
Wishing our friends, partners and customers in China and elsewhere a prosperous andpeaceful year ahead.
Read More Happy New Lunar Year 2024
EANM 2023 Vienna from 9 to 13 September.
Our team will attend the 36th Annual EANM Congress of the European Association of Nuclear Medicine in Vienna from 9 to 13 September. Let’s…
Read More EANM 2023 Vienna from 9 to 13 September.
Chicago SNMMI Annual Meeting.
isoSolutions will participate in the SNMMI Annual Meeting from June 24 – 27, to be held in Chicago, the world’s largest event focused exclusively…
Read More Chicago SNMMI Annual Meeting.
Welcome to isoSolutions John Odom
Prior to joining isoSolutions, John worked as a Business Development Manager, Sales Engineer, and Technical Analyst of Network Operations for a variety of medical,…
Read More Welcome to isoSolutions John Odom
Chinese New Year 2022
Tuesday, February 1st, 2022, and celebrations culminate with the Lantern Festival on February 15th, 2022. Wishing you a prosperous and successful 2022. Happy Chinese…
Read More Chinese New Year 2022
CANM Annual Scientific Conference 2022
The Canadian Association of Nuclear Medicine (CANM) has announced new dates for their 2022 Annual conference. It will now be held Sept 28-Oct 02,…
Read More CANM Annual Scientific Conference 2022
SNMMI 2022 Annual Meeting June 11-14, 2022 in Vancouver.
The SNMMI Annual Meeting is the world’s largest event focused exclusively on meeting the educational and networking needs of the nuclear medicine and molecular…
Read More SNMMI 2022 Annual Meeting June 11-14, 2022 in Vancouver.
Welcome to isoSolutions Roger Lafortune
Roger will contribute to providing service for instruments and support our business growth efforts of Elysia-Raytest portfolio.¬† Prior to joining isoSolutions, Roger Lafortune worked…
Read More Welcome to isoSolutions Roger LafortuneQ BioMed Signs Distribution Agreement with isoSolutions for the Sales of Strontium89 in Canada
Treatment with Strontium89 is available immediately in Canada via Named Patient Program NEW YORK, Aug. 10, 2021 /PRNewswire/ — Q BioMed Inc. (OTCQB: QBIO),…
Read More Q BioMed Signs Distribution Agreement with isoSolutions for the Sales of Strontium89 in Canada
isoSolutions supports Lifetime Giving to Langara College Foundation
isoSolutions Marketing & Management Inc. has been recognized for sponsoring over $5000 to the Lifetime Giving program of the Langara College Foundation. David Drummond,…
Read More isoSolutions supports Lifetime Giving to Langara College Foundation
isoSolutions Announces New Managing Director and Strategic Consultant
isoSolutions Marketing and Management Inc. announces that Mr. David Drummond, Founder, and Managing Director, has decided to retire from the routine affairs of the…
Read More isoSolutions Announces New Managing Director and Strategic Consultant
isoSolutions Marketing & Management Inc. and CNIC partner to promote nuclear medicine applications
TORONTO – February 11, 2020 isoSolutions Marketing & Management Inc. (isoSolutions), an innovative one stop shop when it comes to nuclear medicine products has…
Read More isoSolutions Marketing & Management Inc. and CNIC partner to promote nuclear medicine applications
isoSolutions Welcomes Visitor from Uganda Charity
isoSolutions was very pleased to welcome to its Vancouver office a visitor from the Abetavu children’s home in Uganda. Abetavu is a charity that…
Read More isoSolutions Welcomes Visitor from Uganda CharitySales and Marketing Manager, Asia Appointed
In order to strengthen its position in the Asian market, isoSolutions has appointed a Sales and Marketing Manager for Asia. Mr. Eric Chang will…
Read More Sales and Marketing Manager, Asia Appointed
New strategic commercial Alliance between isoSolutions and Fenix Medica
Vancouver and Buenos Aires, February 2019 We are very proud to announce a new strategic commercial Alliance between isoSolutions and Fenix Medica for the…
Read More New strategic commercial Alliance between isoSolutions and Fenix Medica
Chinese Lunar New Year, Year of the Pig!
Chinese Lunar New Year isoSolutions wishes everyone health and prosperity in the Year of the Pig! Tags: Asia China
Read More Chinese Lunar New Year, Year of the Pig!WFNMB 2026 Congress — Cartagena, Colombia
Join our team for a full showcase of integrated theranostics workflows and generator technology.
Read More WFNMB 2026 Congress — Cartagena, Colombia
SNMMI Annual Meeting Exhibition
Meet our specialists to review cyclotron, targetry, and QC instrumentation options.
Read More SNMMI Annual Meeting ExhibitionHealth Canada Drug Master File (DMF) Submission
68Ge/68Ga generator DMF filed in collaboration with iThemba LABS.
Read More Health Canada Drug Master File (DMF) Submission
The EANM annual meeting
The EANM annual meeting is fast approaching in Europe’s green city on the Alster and Elbe, and it will be a perfect time to…
Read More The EANM annual meetingMolybdenum ( Mo-100)
isoSolutions is pleased to announce the availability of Molybdenum Mo-100 (Radiochemical) with high enrichment and high purity from a cGMP facility. Mo-100 is a…
Read More Molybdenum ( Mo-100)7th Theranostic World Congress.
isoSolutions is participating in the 7th Theranostics World Congress in Santiago, Chile. We will be represented by Marvin Calderon at this conference. Please email…
Read More 7th Theranostic World Congress.EANM 2023 Vienna from 9 to 13 September.
Our team will attend the 36th Annual EANM Congress of the European Association of Nuclear Medicine in Vienna from 9 to 13 September. Let’s…
Read More EANM 2023 Vienna from 9 to 13 September.Chicago SNMMI Annual Meeting.
isoSolutions will participate in the SNMMI Annual Meeting from June 24 – 27, to be held in Chicago, the world’s largest event focused exclusively…
Read More Chicago SNMMI Annual Meeting.
The 35th Annual Congress of the European Association of Nuclear Medicine
isoSolutions will be attending the EANM Annual Meeting to be held, on October 15-19, 2022, in Barcelona, Spain. Arun Singh, the CEO, hopes to…
Read More The 35th Annual Congress of the European Association of Nuclear Medicine
UPPI Annual In-Person Meeting
isoSolutions will be attending the United Pharmacy Partners (UPPI) Annual Meeting on September 14-15 in Charlotte, NC. We are excited to be a part…
Read More UPPI Annual In-Person Meeting
SNMMI Annual Meeting 2022
isoSolutions is pleased to announce that we will be participating in the SNMMI Annual Meeting, the world’s largest event focused exclusively on meeting the…
Read More SNMMI Annual Meeting 2022Welcome to isoSolutions John Odom
Prior to joining isoSolutions, John worked as a Business Development Manager, Sales Engineer, and Technical Analyst of Network Operations for a variety of medical,…
Read More Welcome to isoSolutions John OdomSNMMI 2022 Annual Meeting June 11-14, 2022 in Vancouver.
The SNMMI Annual Meeting is the world’s largest event focused exclusively on meeting the educational and networking needs of the nuclear medicine and molecular…
Read More SNMMI 2022 Annual Meeting June 11-14, 2022 in Vancouver.Welcome to isoSolutions Roger Lafortune
Roger will contribute to providing service for instruments and support our business growth efforts of Elysia-Raytest portfolio.¬† Prior to joining isoSolutions, Roger Lafortune worked…
Read More Welcome to isoSolutions Roger Lafortune
SNMMI 2022 Annual Meeting
SNMMI 2022 Annual Meeting June 11-14, 2022 in Vancouver, BC, Canada. The SNMMI Annual Meeting is the world’s largest event focused exclusively on meeting…
Read More SNMMI 2022 Annual MeetingQ BioMed Signs Distribution Agreement with isoSolutions for the Sales of Strontium89 in Canada
Treatment with Strontium89 is available immediately in Canada via Named Patient Program NEW YORK, Aug. 10, 2021 /PRNewswire/ — Q BioMed Inc. (OTCQB: QBIO),…
Read More Q BioMed Signs Distribution Agreement with isoSolutions for the Sales of Strontium89 in Canada
CANM CONFERENCE
isoSolutions is glad to announce the next Virtual meeting for CANM will be on November 6th, 2021. One-day conference.
Read More CANM CONFERENCE
PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer
ABSTRACT Background: In patients with oligometastatic recurrent prostate cancer, standard treatment is androgen deprivation therapy (ADT). However, ADT has many potential side effects that…
Read More PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer
THE CANM IS MOVING
The Canadian Association of Nuclear Medicine (CANM) Executive Director, H√©l√®ne Samson, retired on March 1, 2021. The CANM will be under the management of…
Read More THE CANM IS MOVING
European Association of Nuclear Medicine
EANM’21 will be host as a virtual congress again. It may be changed to a hybrid event (online and face-to-face combined) if the Corona…
Read More European Association of Nuclear Medicine
Building a resilient Canadian Isotope supply chain critical for patients around the world
New study to explore ways to strengthen delivery of life-saving medical isotopes TORONTO – June 3, 2020) – The Nuclear Innovation Institute (NII) and…
Read More Building a resilient Canadian Isotope supply chain critical for patients around the world
Targeted Radionuclide Therapy
Abstract : Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing of cancer cells is achieved with the use of…
Read More Targeted Radionuclide Therapy
Two world leading research reactors join forces to create dual supply of medical isotope iodine-125
BARCELONA, Spain, 13th October 2019 – McMaster University’s Nuclear Reactor (CAN) and NRG (NL) announced today a unique collaboration between the Netherlands and Canada…
Read More Two world leading research reactors join forces to create dual supply of medical isotope iodine-125
Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics
Androgen ablating drugs increase life expectancy in men with metastatic prostate cancer, but resistance inevitably develops. In a majority of these recurrent tumors, the…
Read More Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics
Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen
5D3 is a new high-affinity murine monoclonal antibody specific for prostate-specific membrane antigen (PSMA). PSMA is a target for the imaging and therapy of…
Read More Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
The role of concomitant peptide receptor radionuclide therapy (PRRT) and capecitabine therapy has shown benefit in gastroenteropancreatic neuroendocrine tumors. However, data reporting its role…
Read More Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008–2018)
Academic journals have published a large number of papers in the therapeutic nuclear medicine (NM) research field in the last 10 years. Despite this,…
Read More Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008–2018)
Bone marrow cell homing to sites of acute tibial fracture: 89Zr-oxine cell labeling with positron emission tomographic imaging in a mouse model
Bone fracture healing is dependent upon the rapid migration and engraftment of bone marrow (BM) progenitor and stem cells to the site of injury.…
Read More Bone marrow cell homing to sites of acute tibial fracture: 89Zr-oxine cell labeling with positron emission tomographic imaging in a mouse model
Reactors back online, expected to alleviate shortage of Mo-99
The worldwide supply of molybdenum-99 is expected to stabilize over the next several weeks as the High Flux Reactor in the Netherlands and the…
Read More Reactors back online, expected to alleviate shortage of Mo-99
Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors
Radiolabeled somatostatin analog therapy has become an established treatment method for patients with well to moderately differentiated unresectable or metastatic neuroendocrine tumors (NETs). The…
Read More Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors
B.C. Cancer Foundation receives anonymous $18 million donation
A generous donor has given the B.C. Cancer Foundation $18.346 million, but insists on remaining anonymous. “Today marks an important moment in cancer research…
Read More B.C. Cancer Foundation receives anonymous $18 million donation
Monosodium glutamate reduces 68Ga-PSMA-11 uptake in salivary glands and kidneys in preclinical prostate cancer model
INTRODUCTION: Prostate-specific membrane antigen (PSMA) is an excellent prostate cancer target for theranostic applications. Many imaging agents showing high sensitivity/specificity for…
Read More Monosodium glutamate reduces 68Ga-PSMA-11 uptake in salivary glands and kidneys in preclinical prostate cancer model
First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer
This first-in-human study demonstrated that 177Lu-EB-PSMA-617 had higher accumulation in mCRPC and that low imaging dose appears to be effective in treating tumors with…
Read More First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors
Prostate cancer is the most frequently diagnosed malignant tumor in men worldwide. Prostate-specific membrane antigen (PSMA) is a surface molecule specifically expressed by prostate…
Read More Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors
2018 Chinese Society of Nuclear Medicine Annual Meeting
Since China was the highlighted country of 2018 SNMMI in Philadelphia, several CSNM board members presented a brief report of 2018 SNMMI to the…
Read More 2018 Chinese Society of Nuclear Medicine Annual Meeting